This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Kerstin Baumarth: Innovator in Ultrafiltration Technology
Introduction
Kerstin Baumarth is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of biopharmaceutical production through her innovative work in ultrafiltration technology. Her expertise has led to advancements that are crucial for the continuous production of biological macromolecular products.
Latest Patents
Kerstin holds a patent for an "Ultrafiltration unit for continuous buffer or medium exchange from a protein solution." This invention relates to an ultrafiltration unit designed for continuous buffer or medium exchange, along with a method for implementing this process. The technology is particularly beneficial for the (semi)continuous production of biopharmaceuticals, including proteins such as monoclonal antibodies and vaccines.
Career Highlights
Throughout her career, Kerstin has worked with prominent companies, including Bayer Aktiengesellschaft and Bayer Technology Services GmbH. Her roles in these organizations have allowed her to apply her innovative ideas in practical settings, contributing to the advancement of biopharmaceutical technologies.
Collaborations
Kerstin has collaborated with esteemed colleagues, including Martin Lobedann and Peter Schwan. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in her field.
Conclusion
Kerstin Baumarth's contributions to ultrafiltration technology exemplify her commitment to advancing biopharmaceutical production. Her innovative patent and career achievements highlight her role as a leading inventor in this critical area of research.